{"nctId":"NCT00310466","briefTitle":"Efficacy and Safety Trial of SLITone(TM) Birch in Subjects With Hayfever","startDateStruct":{"date":"2005-06"},"conditions":["Allergy"],"count":226,"armGroups":[{"label":"Sublingual immunotherapy","type":"ACTIVE_COMPARATOR","interventionNames":["Biological: Sublingual immunotherapy"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Biological: Placebo"]}],"interventions":[{"name":"Sublingual immunotherapy","otherNames":["SLITone(TM) Birch"]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* A history of birch pollen allergy\n* Positive skin prick test to birch\n* Positive conjunctival test to birch\n* Positive specific Immunoglobulin E (IgE) to birch\n\nExclusion Criteria:\n\n* Forced expiratory volume in 1 second (FEV1)\\<70% of predicted value\n* History of seasonal allergy interfering with study\n* History of symptomatic perennial allergy\n* History of emergency visit or admission for asthma in the previous 12 month","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"65 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Daily Rhinoconjunctivitis Symptom Score","description":"A total of 6 rhinoconjunctivitis symptoms are recorded (runny nose, blocked nose, sneezing, itchy nose, gritty feeling/red/itchy eyes, watery eyes). Each symptoms is scored on a scale from 0-3 (no symptoms-severe symptoms). I.e. the total daily score can be 0-18.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4.07","spread":"2.59"},{"groupId":"OG001","value":"4.14","spread":"2.56"}]}]}]},{"type":"SECONDARY","title":"Global Improvement of Rhinoconjunctivitis Symptoms Assessed by the Subjects","description":"The number of participants who reported improved overall symptoms compared to the previous birch pollen season (each patient was asked to compare his/her symptoms in the 2006 birch pollen season with the symptoms in the 2005 birch pollen season).","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"48","spread":null},{"groupId":"OG001","value":"42","spread":null}]}]}]},{"type":"SECONDARY","title":"Adverse Events","description":"An adverse event was defined as: Any untoward medical occurence in a patient or clinical trial subject administered a trial product and which does not necessarily have a causal relationship with this treatment (International Conference of Harmonisation (ICH) Harmonised Tripartite Guideline E2A, Step 5).","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"81","spread":null},{"groupId":"OG001","value":"87","spread":null}]}]}]},{"type":"PRIMARY","title":"Daily Rhinoconjunctivitis Rescue Medication Score","description":"Rescue medication (desloratadine tablets, budesonide nasal spray, prednisone tablets) used for treatment of rhinoconjunctivitis symptoms not controlled by the study medication, were recorded. The total daily score was 0-30 (No medication-Maximum use of medication).","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.76","spread":"3.30"},{"groupId":"OG001","value":"2.54","spread":"2.99"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":4,"n":113},"commonTop":["Oral pruritus","Nasopharyngitis","Paraesthesia oral","Oral discomfort","Eye pruritus"]}}}